SpringWorks Therapeutics, Inc.
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that…
Biotechnology
US, Stamford [HQ]
SWTX/Leadership and Strategy
Risk Factors
Annual
Not Available
No Risk Factor available yet. You can request "Risk Factors" through an email.
Quarter
Not Available